187 related articles for article (PubMed ID: 16860457)
21. Treatment of Burkitt's lymphoma during pregnancy.
Lam MS
Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
[TBL] [Abstract][Full Text] [Related]
22. Marked regression of tumor occupying almost the entire breast following chemotherapy.
Silva BB
Rev Assoc Med Bras (1992); 2011; 57(2):131. PubMed ID: 21537694
[No Abstract] [Full Text] [Related]
23. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report.
Lycette JL; Dul CL; Munar M; Belle D; Chui SY; Koop DR; Nichols CR
Clin Breast Cancer; 2006 Oct; 7(4):342-4. PubMed ID: 17092404
[TBL] [Abstract][Full Text] [Related]
24. [Adriamycin in the combined chemotherapy of metastatic breast cancer].
Izmaĭlova GE; Letiagin VP
Vestn Akad Med Nauk SSSR; 1986; (5):47-51. PubMed ID: 3727784
[No Abstract] [Full Text] [Related]
25. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report.
Ohara N; Teramoto K
Clin Exp Obstet Gynecol; 2000; 27(2):123-4. PubMed ID: 10968352
[No Abstract] [Full Text] [Related]
26. Combination therapy with adriamycin, cyclophosphamide and vicristine for advanced breast cancer supplemented with non cross-resistant combination.
Jain SP; Pandey UC; Tandon US; Jain KK; Agarwal S
Indian J Cancer; 1979; 16(3-4):43-6. PubMed ID: 540959
[No Abstract] [Full Text] [Related]
27. Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer.
Rao MV; Shayne M
Breast Cancer Res Treat; 2009 Sep; 117(1):197-8. PubMed ID: 18592371
[No Abstract] [Full Text] [Related]
28. Response to taxanes in triple negative breast cancer.
Bulut N; Kilickap S; Sari E; Altundag K
Cancer Chemother Pharmacol; 2008 Dec; 63(1):189. PubMed ID: 18317760
[No Abstract] [Full Text] [Related]
29. The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB.
Khaloozadeh H; Yazdanbakhsh P; Homaei-shandiz F
Math Biosci; 2008 Jun; 213(2):151-8. PubMed ID: 18533195
[TBL] [Abstract][Full Text] [Related]
30. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
Tamura K
Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
[No Abstract] [Full Text] [Related]
31. Management of breast cancer during pregnancy using a standardized protocol.
Berry DL; Theriault RL; Holmes FA; Parisi VM; Booser DJ; Singletary SE; Buzdar AU; Hortobagyi GN
J Clin Oncol; 1999 Mar; 17(3):855-61. PubMed ID: 10071276
[TBL] [Abstract][Full Text] [Related]
32. [Breast cancer and pregnancy: review of the literature].
Mathieu E; Merviel P; Barranger E; Antoine JM; Uzan S
J Gynecol Obstet Biol Reprod (Paris); 2002 May; 31(3):233-42. PubMed ID: 12016401
[TBL] [Abstract][Full Text] [Related]
33. [Pharmaceutical services for patients receiving AC chemotherapy].
Higuchi M; Matsuo K; Ureshino Y; Ogata K; Futagami K; Kitamura K; Nishino H
Gan To Kagaku Ryoho; 2009 Feb; 36(2):241-5. PubMed ID: 19223738
[TBL] [Abstract][Full Text] [Related]
34. Primary neuroendocrine carcinoma of the breast, which chemotherapy?
El Hassani LK; Bensouda Y; M'Rabti H; Boutayeb S; Kamouni M; Gamra L; Errihani H
Indian J Cancer; 2009; 46(4):352-4. PubMed ID: 19749475
[No Abstract] [Full Text] [Related]
35. Impact and treatment of cancer during pregnancy.
Weisz B; Meirow D; Schiff E; Lishner M
Expert Rev Anticancer Ther; 2004 Oct; 4(5):889-902. PubMed ID: 15485322
[TBL] [Abstract][Full Text] [Related]
36. Pre-eclampsia following chemotherapy for breast cancer during pregnancy: case report and review of the literature.
Massey Skatulla L; Loibl S; Schauf B; Müller T
Arch Gynecol Obstet; 2012 Jul; 286(1):89-92. PubMed ID: 22395860
[TBL] [Abstract][Full Text] [Related]
37. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature.
Meyer-Wittkopf M; Barth H; Emons G; Schmidt S
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):62-6. PubMed ID: 11489228
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
39. Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.
Saeki T; Nomizu T; Toi M; Ito Y; Noguchi S; Kobayashi T; Asaga T; Minami H; Yamamoto N; Aogi K; Ikeda T; Ohashi Y; Sato W; Tsuruo T
J Clin Oncol; 2007 Feb; 25(4):411-7. PubMed ID: 17179098
[TBL] [Abstract][Full Text] [Related]
40. Treatment of mandibular malignant fibrous histiocytoma during pregnancy.
Otsuka K; Hamakawa H; Sumida T; Tanioka H
J Oral Maxillofac Surg; 2001 Feb; 59(2):220-4. PubMed ID: 11213995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
